Reyes-Leiva, D, Lopez-Contreras, J, Moga, E, Pla-Junca, F, Lynton-Pons, E, Rojas-Garcia, R, Turon-Sans, J, Querol, L, Olive, M, Alvarez-Velasco, R, Caballero-Avila, M, Carbayo, A, Vesperinas-Castro, A, Domingo, P, Illa, I, Gallardo, E, Cortes-Vicente, E. Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2022; 9(4)DOI:10.1212/NXI.0000000000200002. PMID:35728947. IF:8.800(Q1/1D).

Reyngoudt, H, Smith, FE, Araujo, ECD, Wilson, I, Fernandez-Torron, R, James, MK, Moore, UR, Diaz-Manera, J, Marty, B, Azzabou, N, Gordish, H, Rufibach, L, Hodgson, T, Wallace, D, Ward, L, Boisserie, JM, Le Louer, J, Hilsden, H, Sutherland, H, Canal, A, Hogrel, JY, Jacobs, M, Stojkovic, T, Bushby, K, Mayhew, A, Straub, V, Carlier, PG, Blamire, AM. Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy. Journal of Cachexia Sarcopenia and Muscle. 2022; 13(3)DOI:10.1002/jcsm.12987. PMID:35373496. IF:8.900(Q1/1D).

Koehorst, E, Odria, R, Capo, J, Nunez-Manchon, J, Arbex, A, Almendrote, M, Linares-Pardo, I, Natera-de Benito, D, Saez, V, Nascimento, A, Ortez, C, Rubio, MA, Diaz-Manera, J, Alonso-Perez, J, Lucente, G, Rodriguez-Palmero, A, Ramos-Fransi, A, Martinez-Pineiro, A, Nogales-Gadea, G, Suelves, M. An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation. Biomedicines. 2022; 10(6)DOI:10.3390/biomedicines10061372. PMID:35740394. IF:4.700(Q1/3D).

Lopez-Soley, E, Meca-Lallana, JE, Llufriu, S, Blanco, Y, Gomez-Ballesteros, R, Maurino, J, Perez-Miralles, F, Forero, L, Calles, C, Martinez-Gines, ML, Gonzalez-Suarez, I, Boyero, S, Romero-Pinel, L, Sempere, AP, Meca-Lallana, V, Querol, L, Costa-Frossard, L, Sepulveda, M, Solana, E. Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder. Journal of Personalized Medicine. 2022; 12(5)DOI:10.3390/jpm12050743. PMID:35629165. IF:3.508(Q2/4D).

Guasp, M, Martin-Aguilar, L, Sabater, L, Bioque, M, Armangue, T, Martinez-Hernandez, E, Landa, J, Maudes, E, Borras, R, Munoz-Lopetegi, A, Saiz, A, Castro-Fornieles, J, Graus, F, Parellada, E, Querol, L, Dalmau, J. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis. NEUROLOGY. 2022; 98(14)DOI:10.1212/WNL.0000000000200021. PMID:35145006. IF:9.900(Q1/1D).

Blanco-Ruiz, M, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Pascual-Goñi, E, Collet-Vidiella, R, Tejada-Illa, C, Turon-Sans, J, Carbayo, A, Llansó, L, Cortés, E, Pascasio, LA, Querol, L. A nationwide Guillain-Barré syndrome epidemiological study in Spain during the COVID-19 years. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(12)DOI:10.1111/ene.16439. PMID:39132887. IF:3.900(Q1/3D).

Kishnani, PS, Byrne, BJ, Claeys, KG, Díaz-Manera, J, Dimachkie, MM, Kushlaf, H, Mozaffar, T, Roberts, M, Schoser, B, Hummel, N, Kopiec, A, Holdbrook, F, Shohet, S, Toscano, A. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease. Journal Of Patient-Reported Outcomes. 2024; 8(1)DOI:10.1186/s41687-024-00805-w. PMID:39535661. IF:(Q/D).

Mariscal, A, Martínez, C, Goethals, L, Cortés-Vicente, E, Moltó, E, Juárez, C, Barneda-Zahonero, B, Querol, L, Le Panse, R, Gallardo, E. Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis. JOURNAL OF IMMUNOLOGICAL METHODS. 2024; 534DOI:10.1016/j.jim.2024.113748. PMID:39241980. IF:1.600(Q4/9D).